Uniplan Investment Counsel’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6M Buy
264,211
+34,873
+15% +$798K 0.56% 54
2026
Q1
$5.34M Buy
229,338
+9,824
+4% +$212K 0.55% 49
2025
Q4
$4.39M Buy
219,514
+28,044
+15% +$548K 0.44% 65
2025
Q3
$3.49M Sell
191,470
-31,367
-14% -$612K 0.34% 75
2025
Q2
$4.48M Sell
222,837
-20,670
-8% -$398K 0.45% 57
2025
Q1
$4.41M Buy
243,507
+1,493
+0.6% +$26.8K 0.43% 58
2024
Q4
$4.2M Sell
242,014
-2,840
-1% -$54.5K 0.39% 66
2024
Q3
$4.73M Sell
244,854
-4,238
-2% -$78.1K 0.41% 59
2024
Q2
$4.08M Buy
249,092
+62,384
+33% +$968K 0.37% 66
2024
Q1
$2.85M Buy
186,708
+1,461
+0.8% +$22.9K 0.22% 88
2023
Q4
$3M Sell
185,247
-6,659
-3% -$93.1K 0.22% 88
2023
Q3
$2.54M Buy
+191,906
New +$2.49M 0.19% 95

Other funds holding INVA

Uniplan Investment Counsel's INVA Position: Q2 2026 in Review

Uniplan Investment Counsel increased its Innoviva (INVA) stake by 15% in Q2 2026, buying an estimated $798K and bringing the position to 264,211 shares worth $6M. The position accounts for 0.56% of the portfolio, ranked #54.

Uniplan Investment Counsel first reported a position in INVA in Q3 2023 and has held it in 12 quarters since. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Uniplan Investment Counsel held 264,211 shares of Innoviva worth $6M as of Q2 2026.
  • Uniplan Investment Counsel bought 34,873 Innoviva shares in Q2 2026, an estimated $798K.
  • Innoviva made up 0.56% of Uniplan Investment Counsel's portfolio in Q2 2026, its #54 holding.
  • Uniplan Investment Counsel first reported a position in Innoviva in Q3 2023 and has held it in 12 quarters since.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Uniplan Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.